Sagimet Biosciences (SGMT) Current Leases (2022 - 2026)
Sagimet Biosciences (SGMT) posted quarterly Current Leases of $39000.0 for Q1 2026, little changed year-over-year from $39000.0 in Q1 2025, and down 50.0% quarter-over-quarter from $78000.0 in Q4 2025.
Powered by 
Analysis
Sagimet Biosciences (SGMT) Current Leases (2022 - 2026) Analysis & Trends
Sagimet Biosciences' Current Leases history runs 5 years deep, the most recent figure standing at $39000.0 for Q1 2026.
- In Q1 2026, Current Leases changed 0.0% year-over-year to $39000.0; the TTM figure through Mar 2026 stood at $39000.0 (changed 0.0% YoY), while the FY2025 annual figure was $78000.0, changed 0.0% from the prior year.
- Current Leases for Q1 2026 stood at $39000.0, down from $78000.0 in the prior quarter.
- The five-year high for Current Leases was $153000.0 in Q2 2024, with the low at $26000.0 in Q1 2024.
- The 5-year median for Current Leases is $103000.0 (2023), against an average of $95153.8.
- The sharpest annual moves came in 2023 and 2025: Current Leases sank 51.13% in 2023, then soared 50.0% in 2025.
- Sagimet Biosciences' Current Leases stood at $133000.0 in 2022, then tumbled by 51.13% to $65000.0 in 2023, then rose by 20.0% to $78000.0 in 2024, then changed by 0.0% to $78000.0 in 2025, then slumped by 50.0% to $39000.0 in 2026.
- Business Quant data shows SGMT's Current Leases at $39000.0 in Q1 2026, $78000.0 in Q4 2025, and $115000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 11.00 Mn |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | 16.75 Mn |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 21.95 Mn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Sagimet Biosciences | 575.50 Mn | 575.50 Mn | - | 84,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 84,000.00 |
| Mar 31, 2026 | 39,000.00 |
| Dec 31, 2025 | 78,000.00 |
| Sep 30, 2025 | 115,000.00 |
| Jun 30, 2025 | 152,000.00 |
| Mar 31, 2025 | 39,000.00 |
| Dec 31, 2024 | 78,000.00 |
| Sep 30, 2024 | 116,000.00 |
| Jun 30, 2024 | 153,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Dec 31, 2023 | 65,000.00 |
| Sep 30, 2023 | 103,000.00 |
| Jun 30, 2023 | 140,000.00 |
| Dec 31, 2022 | 133,000.00 |